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Abstract The age-related decline in functional capa-
bility is preceded by a reduction in muscle quality. The
purpose of this study was to assess the combined
effects of progressive resistance training (PRT) and
protein supplementation beyond habitual intakes on
upper leg lean tissue mass (LTM), muscle quality and
functional capability in healthy 50–70 years women.
In a single-blinded, randomized, controlled design, 57
healthy older women (age 61.1 ± 5.1 years,
1.61 ± 0.65 m, 65.3 ± 15.3 kg) consumed 0.33 g/kg
body mass of a milk-based protein matrix (PRO) for
12 weeks. Of the 57 women, 29 also engaged in a PRT
intervention (PRO ? PRT). In comparison to the PRO
group (n = 28), those in the PRO ? PRT group had an
increase in upper leg LTM [0.04 (95% CI -0.07 to
0.01) kg vs. 0.13 (95% CI 0.08–0.18) kg, P = 0.027],
as measured by Dual-energy X-ray absorptiometry; an
increase in knee extensor (KE) torque [-1.6 (95% CI
-7.3 to 4.4 N m) vs. 10.2 (95% CI 4.3–15.8 N m),
P = 0.007], as measured from a maximal voluntary
isometric contraction (Con-Trex MJ; CMV AG); and
an increase in extended gait speed [-0.01 (95% CI
-0.52–0.04) m s-1 vs. 0.10 (95% CI 0.05–0.22)
m s-1, P = 0.001] as measured from a maximal
900 m effort. There was no difference between groups
in the time taken to complete 5 chair rises or the number
of chair rises performed in 30 s (P[ 0.05). PRT in
healthy older women ingesting a dietary protein
supplement is an effective strategy to improve upper
leg LTM, KE torque and extended gait speed in healthy
older women.
Keywords Healthy aging  Sarcopenia  Muscle
strength  Functional capability
Introduction
Age associated alterations in skeletal muscle mass and
architecture (Janssen et al. 2000; Thom et al. 2007),
P. Francis (&)
Musculoskeletal Health Research Group, School of
Clinical and Applied Science, Leeds Beckett University,
Leeds LS13HE, UK
e-mail: peter.francis@leedsbeckett.ac.uk
P. Francis  W. Mc Cormack  C. Toomey 
C. Norton  E. Kerin  M. Lyons  P. Jakeman
Human Science Research Unit, Center for Intervention in
Inflammation, Infection and Immunity, University of
Limerick, Limerick, Ireland
P. Francis  W. Mc Cormack  C. Toomey 
C. Norton  P. Jakeman
Food for Health Ireland, University of Limerick,
Limerick, Ireland
J. Saunders
Statistical Consulting Unit/CSTAR @ UL, University of
Limerick, Limerick, Ireland
C. Toomey
Sport Injury Prevention Research Centre, University of




contractile properties (Miller and Toth 2013) and
neuromuscular function (Brown 1972; Luff 1998)
precede the age-related decline in functional capabil-
ity Collectively, these components are thought to
contribute to a muscles ‘quality’ and consequently
there has been a growing interest in understanding the
determinants of muscle performance rather than size.
Expert working groups have recommended older adult
muscle health is evaluated via the measurement of
muscle mass, strength and functional capability (Cruz-
Jentoft et al. 2010; Fielding et al. 2011). Expressing
strength per unit lean tissue mass (LTM) provides an
index of a muscles force generating capacity or muscle
quality and has been reported to be a better predictor of
functional capability in older adults than muscle or
LTM alone (Hairi et al. 2010; Hayashida et al. 2014).
The primary (non-pharmacological) therapeutic
interventions thought to increase muscle mass,
strength and consequently functional capability are
dietary and lifestyle interventions. A recent panel of
experts (Bauer et al. 2013) have recommended that the
recommended daily allowance (RDA) for dietary
protein, currently 0.8 g kg-1 BW day-1, be increased
to at least 1.0–1.2 g kg-1 BW day-1 in healthy older
adults. This is thought necessary to offset the reported
phenomenon of anabolic resistance to protein feeding
that has been observed in the elderly (Breen and
Phillips 2011; Paddon-Jones and Rasmussen 2009).
Protein supplementation (0.165 g kg-1) at the two
smaller meals of the day (normally breakfast and
lunch) for a period of 6 months has been shown to
increase LTM in healthy older adults (Norton et al.
2016).
It is well established, particularly in the young
adult, that dietary protein and progressive resistance
training act synergistically to promote the largest
anabolic response (Breen and Phillips 2013) and
subsequent increase in contractile mass (Cermak et al.
2012). Resistance training interventions of between 8
and 24 weeks have been shown to increase muscle
mass, strength and functional capability in healthy
older adults (Beneka et al. 2005; Eyigor et al. 2007;
Rabelo et al. 2011; Tracy et al. 1999). However, there
is a paucity of literature demonstrating the effects of
resistance training in older adults who have had
dietary protein optimised to at least the minimum
required levels (1.0 g kg-1 BW day-1) The literature
is particularly scant in relation to healthy older or
middle aged (55–64 years; as defined by Glenn et al.
2014) women Therefore, the purpose of this study was
to assess the effects of a PRT intervention on upper leg
LTM, voluntary knee extensor (KE) torque, muscle
quality (KE torque per unit upper leg LTM) and
functional capability in healthy older women receiv-
ing dietary protein supplementation.
Materials and methods
Participants and design
A convenience sample (n = 204) of healthy older
(50–70 years) adults was recruited via email and word
of mouth from the University of Limerick campus
community and surrounding area to take part in the
University of Limerick Healthy Aging Study (Francis
et al. 2016; Norton et al. 2016) Participants were
screened by a medical doctor and provided a full
medical history. Those defined as healthy, i.e. disease
free based on Greig et al. (1994), independent-living,
fully mobile and with no indication of dairy or lactose
intolerance were invited to participate and to provide
written informed consent. All participants were naı¨ve
to resistance training. All procedures were performed
in accordance with the most recent version of the
Declaration of Helsinki and approved by the research
by the Faculty of Education and Health Sciences
Research Ethics Committee (EHSREC 10/45). The
trial was registered at clinicaltrials.gov as
NCT02529124.
For the present investigation, 99 of the participants
described above were female and were recruited to
take part in a randomised, single-blinded, controlled
trial with time (baseline compared with 12 wk) and
treatment group [Protein Supplementation (PRO) or
PRO ? Progressive Resistance Training
(PRO ? PRT)] as independent factors. Simple ran-
domisation was used to assign participants to a
treatment group (PRO, n = 50 or PRO ? PRT,
n = 49). At the outset of the healthy ageing study
whole body LTM was a principal outcome variable.
Assuming a mean total LTM of 48 kg at entry to the
study and an attainable mean change of *1–2% (i.e.
*0.5–1 kg) over the period of the intervention,
statistical power would be [80% at P\ 0.05 for a
study of 34 subjects. To undertake a study of women
would therefore require 34 subjects per group with
appropriately matched non-intervention controls. Six
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(6.1%) of participants were excluded following med-
ical screening, 12 (12.1%) dropped out due to issues
with supplement tolerance, 8 (8%) withdrew due to
injury or illness, 7 (7.1%) dropped out due to time
commitments, 4 (4%) were not compliant with the
supplement, 2 (2%) dropped out due to family issues, 2
(2% dropped out due to relocation and 1 (1%) dropped
out due to being unhappy with group allocation. The
remaining 57 women had measures of dietary intake,
whole and regional body composition, maximal
voluntary isometric KE strength and functional capa-
bility taken prior to undergoing and after 12 weeks of
treatment in the PRO (n = 28) or PRO ? PRT
(n = 29) groups.
Measurement of the dependent variables (Fig. 1)
was normally conducted in the morning, often to
facilitate fasted blood and body composition mea-
surement. In a small number of instances participants
who could not stay for the duration were offered
afternoon testing slots. Participants were asked to
refrain from caffeine intake that morning. Participants
were asked to refrain from strenuous exercise 24 h
before testing and to refrain from any exercise on the
day of testing. Laboratory temperature was kept
consistent at 22–24 C and warm-up procedures were
kept consistent for all measures. The only measure for
which this was not controlled was the extended gait
speed test which took place at a nearby public indoor
running track. Post-testing was completed for all
participants within 1 week of completing the exercise
programme.
Assessment of habitual dietary protein intake
The dietary analysis and regulation of supplement
intake was undertaken by a registered dietician.
Participants had habitual dietary intake assessed using
a 4 days food diary encompassing two week days and
two weekend days. The 4 days food diary was
repeated twice separated by 7 days to ensure partic-
ipants understood the detail required in their food
records and to try and reduce issues with under-
reporting. Food intake data were coded and subse-
quently analysed using WISP (Tinuviel Software,
Anglesey, UK) as previously described by Norton
et al. (2016).
Anthropometric and body composition analysis
Height was measured to the nearest 0.1 cm by using a
stadiometer (Seca) and body mass (BM) was measured
to the nearest 0.1 kg (MC-180MA; Tanita UK Ltd.).
Whole body and regional body composition analysis
was conducted using dual X-ray absorptiometry
(iDXATM; GE Healthcare, Chalfont St Giles, Buck-
inghamshire, UK), in accordance with procedures
used in the University of Limerick Body Composition
Study (Leahy et al. 2013; Norton et al. 2016). The
thigh, representing upper legLTM was measured from
the inferior side of the lesser trochanter until the tibio-
femoral joint.
Maximal voluntary isometric contraction
Maximal voluntary isometric contractions of the knee
extensors of the dominant limb were measured using a
Con-Trex MJ Dynamometer (Con-Trex MJ; CMV
AG, Dubendorf, Switzerland) in accordance with
procedures used by Francis et al. (2016). Muscle
quality was expressed as KE torque per kilogram
upper leg LTM. This index has previously been
reported as an appropriate index of muscle quality
Health Screen (Medical Praconer)
↓
Body Composion Analysis (DXA; Physiotherapist)
↓
Dietary  Intake Analysis (WISP; Diean)
↓
Maximal Voluntary Isometric Torque (Con-Trex; Exercise Scienst)
↓
5 chair stands (s) and the number in completed in 30 s (44 cm chair; Exercise Scienst)
↓
900m gait speed test (225m indoor track; Exercise Scienst)






when using DXA and isokinetic dynamometry as the
measurement tools (Francis et al. 2016).
Functional capability
The ability to rise from a chair was assessed using a
timed 5 repetition chair rise test (Guralnik et al. 1994)
and by counting the number of chair rises completed in
30 s (Jones et al. 1999). Maximal extended gait speed,
using a one or a combination of walking, jogging or
running, was assessed by the time taken to complete
900 m (4 laps of an indoor track) (Francis et al., 2015).
The outside lane of the track was measured as 225 m
using a trundle wheel and all participants were asked
to remain in the outside lane for the duration of the test.
All baseline assessments of isometric strength and
functional capability were repeated after a period of
7 days in order to reduce the potential for a learning
effect. All measurements were carried out by the same
exercise scientist to exclude issues with inter-tester
reliability.
Dietary protein supplementation
Participants were instructed to take a supplement at
their two smaller protein containing meals of the day
i.e. typically breakfast and lunch. Sachets were
provided in powder format and could be mixed with
water to make-up a powdered beverage or incorpo-
rated into meals. Supplements were prescribed relative
to the median 4 levels of participants’ BM i.e.
45–59.9 kg, median of 52.5 kg; 60–74.9 kg, median
of 67.5 kg; 75–89.9 kg, median of 82.5 kg and
90–105 kg, median of 97.5 kg). Each supplement
dose provided 0.165 g protein kg-1 BW day-1 of
median BM. Five flavours were available to off-set
flavour fatigue and to improve compliance. A mixed
excess number of supplement portions were provided
every 4 weeks. with instructions that all used or unused
sachets must be returned. Subjects were blinded to the
supplement composition assigned to them. Compli-
ance was monitored by count-back at the end of each
month.
The milk protein matrix was composed of a 9:2:1
ratio of milk protein concentrate [80% (wt:wt protein);
Glanbia Ingredients Ireland, Kilkenny Ireland]; whey
protein concentrate hydrolysate, degree of hydrolysis
32% [WPC DH 32. 78% (wt:wt protein); Carbery
Food Ingredients, Cork, Ireland; and whey protein
isolate hydrolysate, degree of hydrolysis 45% [WPI
DH 45, 75% (wt:wt protein); Glanbia Ingredients
Ireland]. The total protein concentration was 72.7 g/
100 g powder. The protein matrix was supplemented
with 2187 mg/100 g powder of milk-based calcium
(Trucal; Glanbia Ingredients Ireland) and 57.3 mg/
100 g powder cholecalciferol. On the basis of 2
sachets/d, the daily supplement of milk protein matrix,
milk-based calcium, and cholecalciferol was 0.33, 10,
and 0.26 kg-1 median BM, respectively. A full
breakdown of the supplement composition as recently
been published (Norton et al. 2016).
Progressive resistance training
Supervised (qualified sport and exercise scientist or
chartered physiotherapist) exercise was performed on
three non-consecutive days of week at a University
sports hall. Each session lasted 45–60 min and con-
sisted of a warm up, PRT and a cool down. Compli-
ance to the exercise program was monitored using a
weekly exercise log which was checked by the trainers
administering the PRT session. The majority of
sessions were conducted at 7:45 am to accommodate
those with work commitments. Most participants
would have consumed their dietary protein supple-
ment within 2 h of the exercise session with breakfast.
A smaller number of lunch-time and evening sessions
were also provided for those who could not attend the
early morning sessions. Participants were provided
with equipment (aerobics step and therabands) and
had the option of performing a maximum of 2 of the
sessions at home, however most preferred to attend.
The first 3 weeks of the programme had an
emphasis on ensuring the correct exercise technique
and monitoring the appropriate amount of exercise and
rest intervals for each individual. Between weeks 3
and 12, the programme was designed to promote
muscle hypertrophy (4–6 sets, 8–15 repetitions) as
recommended by Bird et al. (2005). The PRT
programme consisted of a number of upper and lower
body exercises using therabands (T) and body weight
(BW) as the primary resistance. The primary exercises
used throughout the program included squats (T),
lunges (T), hip abduction (T), shoulder press (T),
latissimus dorsi pull-down (or seated row) (T), bicep
curls (T), calf raises (BW), push ups (BW), tricep dips
(BW) and lumbopelvic stabilisation exercises. Ther-
aband exercises were progressed by increasing the
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resistance of the band in ascending order: red, green,
blue and black respectively. Push ups began against a
wall; progressed to hands and knees and eventually
assumed full push up position for some participants.
Calf raises were completed as double legged exercises
initially and then single whilst also varying the depth
of ankle dorsi-flexion. Tricep dips were modified
using step height (15, 20 and 25 cm). Progression was
determined based on the participants post exercise rate
of perceived exertion (RPE) in consultation with the
exercise trainer. Exercises were performed with an
emphasis on the eccentric phase of contraction. The
eccentric phase was conducted to an audible count of
4 s, the position held for 1 s and the concentric phase
completed in 2 s. Exercises were performed alternat-
ing between upper and lower body in order to
minimize fatigue and optimize training time. Partic-
ipants received 30 s rest between sets. The training
programme was set out in 4 9 3 week progressive
cycles (Cycle 1: 3 sets 9 8 - 12 reps; Cycle 2: 3
sets 9 14 reps; Cycle 3: 4 sets 9 10 - 12 reps; Cycle
4: 4 sets 9 12 - 14 reps).
Statistical analysis
Baseline body-composition, muscle function and
functional capability data were checked for normality
of distribution by using the Shapiro–Wilk test and
expressed as means ± SDs for normally distributed
variables and medians (IQRs) for non-normally dis-
tributed variables. An independent t test or Mann–
Whitney U test was used to compare differences
between groups at baseline. The treatment effect was
calculated as the change in outcome measure from
baseline to 12 wk and presented as means or medians
(95% CIs). These data were analysed by univariate
ANOVA or Kruskal–Wallis Test with treatment (PRO
compared with PRO ? PRT) as a fixed factor. To
determine the influence of baseline outcome measures
on the changes seen at 12 wk, data were analysed by
ANCOVA with group as a fixed factors and baseline
value of the dependent variable as the covariate.
Baseline dietary intake and compliance to the dietary
protein supplement were also used as co-variates to
determine their effects on changes in the dependent
variables. Statistical analysis was performed by using
PASW Statistics 22.0 for Windows (SPSS, Inc.).
Significance (2-tailed) was set at P\ 0.05 for all
analyses.
Results
Table 1 displays baseline participant characteristics,
body composition, muscle function and functional
capability for the 57 healthy older women who
completed the study to 12 weeks. There were no
differences in baseline measures between those in the
PRO (n = 28) and the PRO ? PRT (n = 29) groups
(Table 1). Compliance to the dietary supplement was
not different between the PRO and PRO ? PRT
groups respectively (86 ± 10% vs. 82 ± 10%,
P = 0.213).
There was a net positive change in upper leg LTM
in both the PRO and PRO ? EX groups although
greater in the PRO ? EX group (3.6% vs. 1.2%,
P = 0.017). Muscle function as assessed by KE torque
and KE torque per kg upper leg LTM (muscle quality)
demonstrated positive relative gains in the PRO ? EX
group but were negative in the PRO group. Extended
gait speed demonstrated positive absolute and relative
gains in the PRO ? EX group but remained
unchanged in the PRO group (Fig. 2). The time taken
to complete 5 chair rises and the number of chair rises
complete in 30 s remained unchanged in both groups
(Table 2).
Baseline outcome measures, dietary protein intake
at baseline and compliance to the dietary protein
supplement did not have an effect on changes in the
dependent variables when controlled for as covariates
in the analysis (P[ 0.05). Relative changes in upper
leg LTM were not associated with relative changes in
extended gait speed. Relative changes in KE torque
corrected for body mass had the strongest association
with relative change in extended gait speed followed
by muscle quality, although both these correlations
were of moderate strength (Table 3).
Discussion
Ingestion of dietary protein and PRT promote a
synergistic acute anabolic response in healthy adults
(Snijders et al. 2015). Therefore, it would seem
plausible that this strategy would promote the largest
gains in contractile mass and subsequent improvement
in muscle function when extended over a 12-week
period. To our knowledge this is the first randomised
controlled trial to investigate the effects of PRT on
LTM, muscle function and functional capability in
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healthy older women supplemented with dietary
protein to ensure an absolute intake of [1.0 g kg-1
BW day-1. Compared to the PRO group we demon-
strate greater relative gains in upper leg LTM, KE
torque and muscle quality in the PRO ? PRT group.
Functional capability as measured by extended gait
speed demonstrated greater absolute and relative gains
in the PRO ? PRT group compared to the PRO group.
Functional capability as measured by short (5 chair
rises) or extended (number of chair rises in 30 s) chair
rise tests remained unchanged in both groups. Relative
changes in KE torque corrected for upper leg LTM or
Fig. 2 Mean and individual relative percentage change in dependent variables
Table 1 Baseline participant characteristics, body composition, muscle function and functional capability in healthy older women
PRO (n = 28) PRO ? PRT (n = 29) Pa
Age (years) 61.8 ± 4.5 60.4 ± 5.6 0.324
Height (cm) 160.4 (7.8) 162.0 (6.0) 0.637
Body mass (kg) 68.6 ± 12.2 64.9 (10.9) 0.666
BMI (kg m-2) 26.1 ± 3.9 24.7 (4.1) 0.439
Body fat (%) 37.7 ± 6.6 36.7 ± 5.0 0.515
LTM (kg) 39.9 ± 4.8 39.9 ± 3.5 0.811
Protein intake (g kg day-1) 1.22 ± 0.34 1.29 ± 0.34 0.432
Upper limb LTM (kg) 3.68 ± 0.60 3.71 ± 0.52 0.865
Knee extensor peak torque (N m) 89.0 (26.5) 86.2 ± 22.8 0.346
Muscle quality (N m kg-1/LTM) 25.7 ± 6.5 23.3 ± 5.8 0.153
900 m gait speed (m s-1) 2.14 (0.50) 2.29 ± 0.47 0.587
5 Chair repetition (s) 8.3 ± 2.0 8.4 (2.4) 0.696
Chair repetitions in 30 s (n)b 18 ± 5 18 ± 4 0.826
Values are means ± SDs or medians (IQR). No significant differences were found between groups
a P values for the difference between PRO and PRO ? EX groups analysed by independent t test or Mann–Whitney U test
b PRO, n = 17, PRO ? PRT, n = 14
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body mass had a moderate association with relative
changes in extended gait speed.
Whole body LTM remained unchanged between
groups after the 12-week intervention, whilst upper leg
LTM demonstrated a modest 3.6% (*130 g) increase
in the PRO ? EX group. In light of the measurement
error (2.3%) for upper leg LTM using DXA this
difference may be considered negligible. However, as
95% confidence intervals do not cross zero in the
PRO ? PRT group, it is more likely that a true
difference does exist and that DXA overestimates
baseline skeletal muscle mass and underestimate
changes in response to PRT (Delmonico et al. 2007;
Maden-Wilkinson et al. 2013). This is largely due to
DXA’s inability to differentiate between skin, skeletal
muscle and other fat-free tissue components (Wang
et al. 1996). This methodology may mask changes in
LTM at the whole body level and underestimate
changes at the upper leg. The fact that DXA
Table 2 Change in LTM, muscle function and functional capability in healthy older women
Treatment effect Treatment effect (%)
D Pa 1 - b D Pa 1 - b
LTM (kg)
PRO -0.21 (-0.8 to 0.3) 0.133 -0.6 (-2.0 to 0.9) 0.142
PRO ? EX 0.34 (-0.2 to 0.9) 1.0 (-0.5 to 2.5)
Upper leg LTM (kg)
PRO 0.04 (-0.07 to 0.01) 0.027 0.606 1.2 (-0.2 to 2.6) 0.017 0.680
PRO ? EX 0.13 (0.08–0.18) 3.6 (2.3 to 5.0)
Knee extensor torque (N m)
PRO -1.6 (-7.3 to 4.4) 0.007 0.784 -1.3 (-7.8 to 5.9) 0.008 0.766
PRO ? EX 10.2 (4.3–15.8) 12.7 (5.6–19.0)
Muscle quality (N m kg-1)
PRO -0.8 (-2.2 to 1.0) 0.062 -2.4 (-8.1 to 5.1) 0.046 0.520
PRO ? EX 1.8 (0.0 to 3.2) 9.0 (1.6–14.6)
900 m gait speed (m s-1)b
PRO -0.01 (-0.52 to.-0.04) 0.001 -0.4 (-2.6 to 1.8) 0.001
PRO ? EX* 0.10 (0.05–0.22) 3.8 (3.0–8.4)
5 Chair REP (s)b
RO -0.01 (-0.48 to 0.45) 0.749 0.8 (-4.9 to 6.5) 0.793
PRO ? EX* 0.01 (-0.23 to 0.60) 0.1 (-2.8 to 6.8)
Chair REP 30 s (n)c
PRO -1.0 (-1.8 to -0.2) 0.572 -4.2 (-7.8 to -6.2) 0.904
PRO ? EX* -0.5 (-2.0 to 0.0) -5.3 (-10.0 to 0.0)
LTM lean tissue mass, REP repetition, 1 - b statistical power
Data are means (95% CIs) and * medians (Bootstrap 95% CIs). Treatment effect = (value at 12 week - value at baseline)
a P values for the difference in treatment effect, PRO compared with PRO ? PRT, analysed by univariate ANOVA or Kruskall
Wallis Test with treatment group as a fixed factor
b PRO, n = 25, PRO ? PRT, n = 26
c PRO, n = 17, PRO ? PRT, n = 14
Table 3 Pearson correlations between relative change in lab-
oratory measures of muscle function and relative change in
900 m performance
D % Laboratory measures D % Gait speed (m/s)a P*
Upper leg LTM (kg) 0.005 0.972
KE torque/BM (N m kg-1) 0.514 \0.001
Muscle quality (N m kg-1) 0.478 \0.001
a Pearsons r
* P values for the correlations reported
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underestimates skeletal muscle change during inter-
ventions is perhaps also the first step towards
explaining the 3.5 times greater increase in KE torque
compared with upper leg LTM in the PRO ? PRT
group. In fact, the ratio of age-related difference in
upper leg LTM and KE torque (1:3) previously
reported in this population (Francis et al. 2016)
appears to mirror the ratio of intervention led
improvement in the present investigation. While the
work of Ha¨kkinen et al. (2001) demonstrates a closer
approximation of increases in mass (5.5%) and KE
torque (8.7%) when using computed tomography (CT)
to measure responses to 12 weeks PRT in women
(*74 years), it is unlikely that DXA underestimates
threefold increases in upper leg skeletal muscle mass.
The magnitude of KE torque increase is lightly to
due to improvements in muscle quality. The increase
in muscle quality is likely due to a reversal of some of
the adverse physiological changes associated with
muscle ageing such as a reduction in the angle of
muscle pennation (Thom et al. 2007), the number and
diameter of type I and type IIA muscle fibres (Lexell
et al. 1988; Nilwik et al. 2013) and the number of
active motor units (Luff 1998), all of which, are
compounded by an increase in connective tissue and
fat infiltration (Taaffe et al. 2009). These changes in
muscle quality reduce the contractile mass and
subsequently the force generating capacity of the
muscle. Participants in this study were naı¨ve to PRT.
The improvement in muscle quality and functional
capability may also in part be due to a normal response
to exercise training separate to that of reversing
adverse changes associated ageing. For example, at
the cellular level, the mitochondrial response to
exercise training is an intact process in aging skeletal
muscle and this may contribute to the beneficial effects
of exercise on musculoskeletal health with aging
(Cobley et al. 2015). Furthermore, at the whole body
level, cessation of exercise in trained older adults
increases the fatty infiltration and reduces strength of
the muscle while resumption has the opposite effect
(Taaffe et al. 2009). It is perhaps the neurological
aspects of muscle quality which are restored initially
by PRT in healthy older or middle aged adults;
accompanied by only modest increases in muscle
mass. The basis for this suggestion comes from the fact
that we did not observe the absolute (0.5–0.7 kg) nor
relative (1.2–1.9%) improvements in whole body
LTM reported from women undergoing PRT in
previous literature (Rabelo et al. 2011; Tracy et al.
1999). One possible explanation for this is that these
studies have tended to investigate women greater than
60 years often with a mean age of*70 years. The fact
that strength improvements in these studies are similar
to ours but LTM gains are greater may suggest that
muscle mass and function are more closely linked in
older adults [60 years. Support for this suggestion
comes from the work of Newman et al. (2003) who
reports an 8.6% per decade decline in leg LTM and an
accompanying 10.1% change in muscle quality. The
proximity between changes in muscle mass and
strength in older adults suggests there is a threshold,
after which, changes in muscle quality which began
earlier in life (*45 years) are now accompanied by
declines in skeletal muscle mass.
The findings of an improvement in KE peak torque
and subsequent improvement in muscle quality is in
agreement with previous literature which has reported
older women to have a 7–21% (6–13 N m) increase in
KE peak torque from interventions lasting between 8
and 24 weeks (Beneka et al. 2005; Damush and
Damush 1999; Rabelo et al. 2011; Tracy et al. 1999).
This relatively narrow range of improvements in spite
of the varying duration and modes of resistance
exercise employed suggests that muscles worked close
to their force generating capacity will get stronger
(Morton et al. 2016). This suggestion is underpinned
by the work of Ha¨kkinen et al. (2001) who reported
activation of the largest motor units to occur after the
first 7 weeks of resistance training. Our results also
support existing data which suggest that age-related
difference (Janssen et al. 2000; Lynch et al. 1999) and
intervention led improvements (Ha¨kkinen et al. 2001)
in skeletal muscle mass are greatest at the thigh region.
The identification of laboratory measures of LTM
and muscle function which can detect age-related
difference and are sensitive to therapeutic intervention
become clinically relevant when associated with
functional capability. We have previously reported
the chair rise and extended gait speed tests used in this
study as capable of detecting age-related difference in
healthy 50–70 years women Francis et al. 2015).
Furthermore, all measures were associated with max-
imal KE torque. In the present investigation the short
(5 repetitions) and extended (number complete in
30 s) chair rise tests were not different between the
PRO and PRO ? EX after 12 weeks. Therefore, it
would appear that while chair rise tests can detect age-
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related difference in functional capability between
decades (6th and 7th) they do not have the sensitivity
to detect changes as a result of short term therapeutic
intervention. The improvement in extended gait speed
for those in the PRO ? EX group, practically speak-
ing, was equivalent to a 20 s reduction in the time
taken to complete 900 m. This test may demonstrate
greater sensitivity due to enabling participants to
perform to a greater maximum pre and post interven-
tion. Tests of short duration (\30 s) may suffer from a
ceiling effect when used in short term interventions
with healthy older adults. Relative improvements in
extended gait speed were associated with relative
improvement in KE peak torque and muscle quality
but not upperleg LTM. These findings are consistent
with our cross-sectional work which reported associ-
ations between upper leg LTM, KE torque, muscle
quality and measures of functional capability in a
larger (n = 128) sample of healthy 50–70 years
(Francis 2014). Interestingly, compared to muscle
quality, KE torque corrected for body mass had a
consistently stronger association with all measures of
functional capability. The association although highly
statistically significant is still moderate (r = 0.514,
P =\0.001) which is most likely due to the number
of other factors which influence the time taken to
complete 900 m. It is likely that an increase in
capillary angiogenesis and mitochondrial biogenesis
would occur in participants exposed to a new training
stimulus involving local muscular endurance, improv-
ing delivery and extraction of oxygen by working
muscles (Holloszy and Coyle 1984). These findings
support those of Visser et al. (2005), Hairi et al. (2010)
and Hayashida et al. (2014) who have consistently
identified muscle strength rather than LTM as a key
determinant of functional capability in older adults
[65 years. There are two potentially important find-
ings from this aspect of the work (a) KE torque
corrected for body mass may be as relevant to the
performance of functional tasks as muscle quality;
most likely due to the fact that it represents strength
relative to the body mass being accelerated and
(b) extended gait speed tests; which allow perfor-
mance to a greater maximum than short test batteries
may be required to detect changes in short term
interventions using healthy older women. The basis
for this suggestion comes from data reported by Glenn
et al. (2014) which indicated no difference in 10 m
habitual gait speed between older adults who are
sedentary, recreationally active or masters athletes and
no difference in 10 m maximal gait speed between
those who are sedentary or recreationally active. We
previously reported extended gait speed, as used in this
study, but not short (10 m) gait speed to demonstrate
age-related difference between the 6th and 7th decade
of life (Francis et al. 2015). These findings combined
with the findings in the present study suggest healthy
older adults need to be challenged sufficiently in order
to establish meaningful degradations in capacity and/
or response to intervention.
The fact that baseline dietary protein intake
(P = 0.596) or supplement compliance (P = 0.286)
had no effect on change in upperleg LTM is perhaps
due to the fact that the mean baseline intake for the
intervention cohort (n = 57) was 1.22 g proteinkg-1
BW day-1 prior to supplementation. An expert work-
ing group (Bauer et al. 2013) suggested an intake of
1.0–1.2 g protein kg-1 BW day-1 was required to
overcome the anabolic resistance identified in aging
muscle. It may be that current intakes in this conve-
nience sample of 50–70 years old women were
already optimised. Our results are in agreement with
that of Andrews et al. (2006) in men and women,
Kukuljan et al. (2009) in men and Chale´ et al. (2013) in
mobility limited older adults who have reported
protein intake at baseline and whey protein supple-
mentation not to have significant effect on changes in
LTM as a result of PRT. Macnaughton et al. (2016)
have demonstrated that 40 g of protein supplementa-
tion post whole body resistance training increases 24 h
MPS to a greater extent than 20 g in healthy young
men. Our protein dose post exercise (normally break-
fast) was *8 to 16 g dependent on BM and *16 to
32 g per day when both supplements are included.
Although this would have led to an even distribution of
protein (* 30 g protein/meal) throughout the day it
may not have been sufficient to optimise MPS post
exercise, particularly in older adults which may
require additional protein to overcome anabolic resis-
tance. Furthermore, although we carefully determined
baseline dietary protein intake at baseline so that we
could supplement to optimise the daily dose; we did
not monitor dietary protein intake throughout the
intervention and therefore cannot be sure dietary
protein intake remained adequate throughout the
intervention. There was a high drop-out rate in our
study and almost half of it came from issues related to
supplement tolerance and compliance. This is despite
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the availability of 5 flavors to off-set flavor fatigue and
to improve compliance. Researchers may want to
consider which mode of protein delivery might
maximise compliance. 22% of participants dropped
out due to injury or illness (not study related) and 19%
due to time commitments. A consideration for future
research of this nature is the time cost required from
participants, particularly those who are still in full-
time employment. This is largely influenced by the
number of dependent or control variables being
measured during the intervention period and may
have influenced dropout rate. In summary, we report
positive gains in upper leg LTM, KE torque and
muscle quality for those undergoing 12 weeks of PRT
in addition to protein supplementation beyond habit-
ual intakes. Extended gait speed, as assessed by a
maximal 900 m effort, was the only measure of
functional capability capable of detecting change as a
result of a PRT intervention. Improvements in
extended gait speed were associated with improve-
ments in KE strength and muscle quality but not upper
leg LTM. Future studies in healthy older adults should
consider optimising the protein dose, habitual distri-
bution and post exercise intake to see if LTM and
muscle function responses can be augmented post PRT
interventions.
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